Ameriprise
KANG

Ameriprise’s iKang Healthcare Group, Inc. KANG Stock Holding History

Ameriprise’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-272
Closed -$5K – 4777
2014
Q3 		$5K Buy
272
+267
+5,340% +$5.21K ﹤0.01% 5155
2014
Q2 		$0 Buy
+5
New +$75 ﹤0.01% 5723

Other funds holding KANG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NCMC
NewQuest Capital Management (Cayman) Grand Cayman, Cayman Islands $16.2M AUM 27.4% 1-Year Est. Return
ASI
All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return
MAM
Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return

Ameriprise's KANG Position: Q4 2014 in Review

Ameriprise sold out of iKang Healthcare Group, Inc. (KANG) in Q4 2014, closing a stake of 272 shares — an estimated $5K sold.

Ameriprise first reported a position in KANG in Q2 2014 and held it in 2 quarters. The position peaked at $5K in Q3 2014. 50 funds tracked by Wall St. Rank hold KANG as of Q4 2014.

  • Ameriprise reported no remaining iKang Healthcare Group, Inc. position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 272 iKang Healthcare Group, Inc. shares in Q4 2014, an estimated $5K.
  • Ameriprise first reported a position in iKang Healthcare Group, Inc. in Q2 2014 and held it in 2 quarters.
  • Ameriprise's iKang Healthcare Group, Inc. position peaked at $5K in Q3 2014.
  • 50 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.